(Q43267044)

17 November 2017

title

Denosumab: a promising drug for the prevention and treatment of osteoporosis (English)

1 reference

17 November 2017

0 references

E Michael Lewiecki

1

1 reference

17 November 2017

publication date

1 July 2006

1 reference

17 November 2017

1 reference

17 November 2017

volume

2

1 reference

17 November 2017

issue

4

1 reference

17 November 2017

page(s)

517-525

1 reference

How many women have osteoporosis now?

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Perspective. How many women have osteoporosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Compliance with drug therapies for the treatment and prevention of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Compliance with pharmacologic therapy for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Denosumab in postmenopausal women with low bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

The role of the immune system in the pathophysiology of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

The long and the short of bone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

The effect of a single dose of osteoprotegerin in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Regulation of cancer cell migration and bone metastasis by RANKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17455057.2.4.517

21 January 2018

Identifiers

DOI

10.2217/17455057.2.4.517

1 reference

release_ngkmdcxy55b3leqtxv45swzsyu

17 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ngkmdcxy55b3leqtxv45swzsyu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference